Safety of Antithrombotic Therapy in East Asian Patients

Overview

Journal Intern Emerg Med

Publisher Springer

Specialties Emergency Medicine
General Medicine

Date 2021 Mar 8

PMID 33683537

Citations 3

Authors

Shinya Goto

Shinichi Goto

Affiliations

Soon will be listed here.

Abstract

Antithrombotic agents are widely used on the globe for prevention of thrombotic events such as atherothrombotic events and thromboembolic stroke in atrial fibrillation or for prevention and treatment of venous thromboembolism. However, the net clinical benefit of antithrombotic intervention may differ substantially in various sub-population of patients. Here, the authors attempt to address the risk of serious bleeding in East Asian as compared to the other regions of the world. The community-based epidemiological data suggest numerically higher risk of hemorrhage stroke in East Asian as compared to the globe. Importantly, the life-time risk of ischemic stroke in East Asia is higher than that of the globe. Regarding the serious bleeding risk in East Asians with the use of antithrombotic agents, various clinical trials and international registries provided conflicting information. It is hard to draw generalized conclusion, but there are some specific sub-population in East Asian with higher risk of specific serious bleeding events with the use of specific antithrombotic agents such as the risk of intra-cranial bleeding (ICH) with Vitamin K antagonists. Specific characteristics in East Asian such as higher prevalence of lacunar stroke may contribute higher risk of ICH in East Asian, but the detailed mechanism is still to be elucidated. In conclusion, further investigations are necessary to clarify the specific conditions where the risk of serious bleeding events in East Asian patients differ substantially compared to the global. In addition, further understanding of the mechanisms causing the different bleeding response in specific conditions in East Asian is awaited.

Citing Articles

Low-dose prasugrel versus standard-dose ticagrelor in east Asian patients with acute coronary syndrome.

Wu Y, Wu C, Huang H, Wu C, Huang C, Wang C J Thromb Thrombolysis. 2024; 57(4):537-546.

PMID: 38555552 DOI: 10.1007/s11239-024-02965-4.

Outcomes for patients hospitalized with acute myocardial infarction and cerebral infarction in the United States: insights from the National Inpatient Sample.

Kwok C, Abbas K, Qureshi A, Lip G Intern Emerg Med. 2023; 18(2):375-383.

PMID: 36746890 DOI: 10.1007/s11739-022-03172-w.

Chronic Kidney Disease with Mild and Mild to Moderate Reduction in Renal Function and Long-Term Recurrences of Atrial Fibrillation after Pulmonary Vein Cryoballoon Ablation.

Boriani G, Iacopino S, Arena G, Pieragnoli P, Verlato R, Manfrin M J Cardiovasc Dev Dis. 2022; 9(5).

PMID: 35621837 PMC: 9147782. DOI: 10.3390/jcdd9050126.

References

Bhatt D, Steg P, Ohman E, Hirsch A, Ikeda Y, Mas J . International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA. 2006; 295(2):180-9. DOI: 10.1001/jama.295.2.180. View

Uchiyama S, Goto S, Origasa H, Uemura N, Sugano K, Hiraishi H . Major cardiovascular and bleeding events with long-term use of aspirin in patients with prior cardiovascular diseases: 1-year follow-up results from the Management of Aspirin-induced Gastrointestinal Complications (MAGIC) study. Heart Vessels. 2019; 35(2):170-176. PMC: 6981314. DOI: 10.1007/s00380-019-01484-0. View

Goto S, Ikeda Y, Shimada K, Uchiyama S, Origasa H, Kobayashi H . One-year cardiovascular event rates in Japanese outpatients with myocardial infarction, stroke, and atrial fibrillation. -Results From the Japan Thrombosis Registry for Atrial Fibrillation, Coronary, or Cerebrovascular Events (J-TRACE).-. Circ J. 2011; 75(11):2598-604. DOI: 10.1253/circj.cj-11-0378. View

Ntaios G, Papavasileiou V, Makaritsis K, Vemmos K, Michel P, Lip G . Real-World Setting Comparison of Nonvitamin-K Antagonist Oral Anticoagulants Versus Vitamin-K Antagonists for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis. Stroke. 2017; 48(9):2494-2503. DOI: 10.1161/STROKEAHA.117.017549. View

Verheugt F, Granger C . Oral anticoagulants for stroke prevention in atrial fibrillation: current status, special situations, and unmet needs. Lancet. 2015; 386(9990):303-10. DOI: 10.1016/S0140-6736(15)60245-8. View

Lip G, Lane D . Stroke prevention in atrial fibrillation: a systematic review. JAMA. 2015; 313(19):1950-62. DOI: 10.1001/jama.2015.4369. View

January C, Samuel Wann L, Alpert J, Calkins H, Cigarroa J, Cleveland Jr J . 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014; 64(21):e1-76. DOI: 10.1016/j.jacc.2014.03.022. View

Ageno W, Haas S, Weitz J, Goldhaber S, Turpie A, Goto S . Characteristics and Management of Patients with Venous Thromboembolism: The GARFIELD-VTE Registry. Thromb Haemost. 2018; 119(2):319-327. DOI: 10.1055/s-0038-1676611. View

Khan F, Huang H, Datta Y . Direct oral anticoagulant use and the incidence of bleeding in the very elderly with atrial fibrillation. J Thromb Thrombolysis. 2016; 42(4):573-8. PMC: 5042846. DOI: 10.1007/s11239-016-1410-z. View

10.

Claxton J, MacLehose R, Lutsey P, Norby F, Chen L, ONeal W . A new model to predict major bleeding in patients with atrial fibrillation using warfarin or direct oral anticoagulants. PLoS One. 2018; 13(9):e0203599. PMC: 6130859. DOI: 10.1371/journal.pone.0203599. View

11.

Patrono C, Garcia Rodriguez L, Landolfi R, Baigent C . Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med. 2005; 353(22):2373-83. DOI: 10.1056/NEJMra052717. View

12.

Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R . Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009; 373(9678):1849-60. PMC: 2715005. DOI: 10.1016/S0140-6736(09)60503-1. View

13.

Vandvik P, Lincoff A, Gore J, Gutterman D, Sonnenberg F, Alonso-Coello P . Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141(2 Suppl):e637S-e668S. PMC: 3278064. DOI: 10.1378/chest.11-2306. View

14.

Levine G, Bates E, Bittl J, Brindis R, Fihn S, Fleisher L . 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update.... Circulation. 2016; 134(10):e123-55. DOI: 10.1161/CIR.0000000000000404. View

15.

Hori M, Matsumoto M, Tanahashi N, Momomura S, Uchiyama S, Goto S . Rivaroxaban vs. warfarin in Japanese patients with atrial fibrillation – the J-ROCKET AF study –. Circ J. 2012; 76(9):2104-11. DOI: 10.1253/circj.cj-12-0454. View

16.

Goto S, Ikeda Y, Chan J, Wilson P, Yeo T, Liau C . Risk-factor profile, drug usage and cardiovascular events within a year in patients with and at high risk of atherothrombosis recruited from Asia as compared with those recruited from non-Asian regions: a substudy of the REduction of.... Heart Asia. 2016; 3(1):93-8. PMC: 4898548. DOI: 10.1136/ha.2010.002691. View

17.

Dorji P, Tshering G, Na-Bangchang K . CYP2C9, CYP2C19, CYP2D6 and CYP3A5 polymorphisms in South-East and East Asian populations: A systematic review. J Clin Pharm Ther. 2019; 44(4):508-524. DOI: 10.1111/jcpt.12835. View

18.

Gaikwad T, Ghosh K, Shetty S . VKORC1 and CYP2C9 genotype distribution in Asian countries. Thromb Res. 2014; 134(3):537-44. DOI: 10.1016/j.thromres.2014.05.028. View

19.

Jeong Y, Tantry U, Kim I, Koh J, Kwon T, Park Y . Effect of CYP2C19*2 and *3 loss-of-function alleles on platelet reactivity and adverse clinical events in East Asian acute myocardial infarction survivors treated with clopidogrel and aspirin. Circ Cardiovasc Interv. 2011; 4(6):585-94. DOI: 10.1161/CIRCINTERVENTIONS.111.962555. View

20.

Ueda K, Hasuo Y, Kiyohara Y, Wada J, Kawano H, Kato I . Intracerebral hemorrhage in a Japanese community, Hisayama: incidence, changing pattern during long-term follow-up, and related factors. Stroke. 1988; 19(1):48-52. DOI: 10.1161/01.str.19.1.48. View